Cargando…

BDP1 Alterations Correlate with Clinical Outcomes in Breast Cancer

SIMPLE SUMMARY: Breast cancer accounts for 30% of all new cancer diagnoses in the United States. The most common type of breast cancer is invasive breast cancer. A hallmark trait of breast cancer is uncontrolled cell growth due to genetic alterations. TFIIIB-mediated RNA polymerase III transcription...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cabarcas-Petroski, Stephanie, Schramm, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996959/ https://www.ncbi.nlm.nih.gov/pubmed/35406430 http://dx.doi.org/10.3390/cancers14071658

Ejemplares similares

BDP1 as a biomarker in serous ovarian cancer
por: Cabarcas‐Petroski, Stephanie, et al.
Publicado: (2022)

MAF1 is a predictive biomarker in HER2 positive breast cancer
por: Cabarcas-Petroski, Stephanie, et al.
Publicado: (2023)

A meta-analysis of BRF2 as a prognostic biomarker in invasive breast carcinoma
por: Cabarcas-Petroski, Stephanie, et al.
Publicado: (2020)

Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein
por: Koo, Jana, et al.
Publicado: (2015)

The Putative Bromodomain Protein PfBDP7 of the Human Malaria Parasite Plasmodium Falciparum Cooperates With PfBDP1 in the Silencing of Variant Surface Antigen Expression
por: Quinn, Jennifer E., et al.
Publicado: (2022)

Gene Expression and DNA Methylation in Human Papillomavirus Positive and Negative Head and Neck Squamous Cell Carcinomas
por: Hinić, Snežana, et al.
Publicado: (2022)

Structural insights into acetylated histone ligand recognition by the BDP1 bromodomain of Plasmodium falciparum
por: Singh, Ajit Kumar, et al.
Publicado: (2022)

Molecular mechanisms of Bdp1 in TFIIIB assembly and RNA polymerase III transcription initiation
por: Gouge, Jerome, et al.
Publicado: (2017)

Comment on Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364
por: Schramm, Laura
Publicado: (2022)

RNA polymerase III transcription in cancer: the BRF2 connection
por: Cabarcas, Stephanie, et al.
Publicado: (2011)

Differential expression of the TFIIIB subunits Brf1 and Brf2 in cancer cells
por: Cabarcas, Stephanie, et al.
Publicado: (2008)

Linkage Study and Exome Sequencing Identify a BDP1 Mutation Associated with Hereditary Hearing Loss
por: Girotto, Giorgia, et al.
Publicado: (2013)

TFIIIB Subunit Bdp1 Participates in RNA Polymerase III Transcription in the Protozoan Parasite Leishmania major
por: Román-Carraro, Fiordaliso C., et al.
Publicado: (2019)

BDP/FF NEXThaler to Improve Asthma Control Status in the Real World: The NEWTON Study
por: Braido, Fulvio, et al.
Publicado: (2023)

Biomarker discovery process at binomial decision point (2BDP): Analytical pipeline to construct biomarker panel
por: Chakraborty, Nabarun, et al.
Publicado: (2023)

Crystallographic characterization of the metal–organic framework Fe(2)(bdp)(3) upon reductive cation insertion
por: Biggins, Naomi, et al.
Publicado: (2020)

An apicomplexan bromodomain protein, TgBDP1, associates with diverse epigenetic factors to regulate essential transcriptional processes in Toxoplasma gondii
por: Fleck, Krista, et al.
Publicado: (2023)

Human Maf1 negatively regulates RNA Polymerase III transcription via the TFIIB family members Brf1 and Brf2
por: Rollins, Janet, et al.
Publicado: (2007)

BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study
por: Li, Xiaoqing, et al.
Publicado: (2021)

The Saccharomyces cerevisiae RNA polymerase III recruitment factor subunits Brf1 and Bdp1 impose a strict sequence preference for the downstream half of the TATA box
por: Tsihlis, Nick D., et al.
Publicado: (2006)

HFA-BDP Metered-Dose Inhaler Exhaled Through the Nose Improves Eosinophilic Chronic Rhinosinusitis With Bronchial Asthma: A Blinded, Placebo-Controlled Study
por: Kobayashi, Yoshiki, et al.
Publicado: (2018)

Laser performance and investigation of the optimal density functional and the dependence of the basis sets for (E, E)-2,5-bis (3,4-dimethoxystyryl) pyrazine (BDP) molecule
por: Sakr, Mahmoud A. S., et al.
Publicado: (2021)

Conjugated Polymers Containing Building Blocks 1,3,4,6-Tetraarylpyrrolo[3,2-b]pyrrole-2,5-dione (isoDPP), Benzodipyrrolidone (BDP) or Naphthodipyrrolidone (NDP): A Review
por: Deng, Zhifeng, et al.
Publicado: (2019)

Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364”
por: Li, Xiaoqing, et al.
Publicado: (2022)

Genetic analysis of oligo-recurrence breast cancer: correlation with clinical outcomes
por: Jiang, Kuikui, et al.
Publicado: (2023)

BRIP1 overexpression is correlated with clinical features and survival outcome of luminal breast cancer subtypes
por: Gupta, Ishita, et al.
Publicado: (2017)

High HSPB1 expression predicts poor clinical outcomes and correlates with breast cancer metastasis
por: Huo, Qin, et al.
Publicado: (2023)

Correlation of androgen receptor with ultrasound, clinicopathological features and clinical outcomes in breast cancer
por: Zhang, Xudong, et al.
Publicado: (2023)

PD-1 and PD-L1 correlated gene expression profiles and their association with clinical outcomes of breast cancer
por: Jiang, Cui, et al.
Publicado: (2019)

Autoantibodies to endostatin in patients with breast cancer: correlation to endostatin levels and clinical outcome
por: Bachelot, T, et al.
Publicado: (2006)

FLI1 Expression is Correlated with Breast Cancer Cellular Growth, Migration, and Invasion and Altered Gene Expression
por: Scheiber, Melissa N., et al.
Publicado: (2014)

Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer
por: Palazón-Carrión, Natalia, et al.
Publicado: (2021)

Altered intracellular region of MUC1 and disrupted correlation of polarity-related molecules in breast cancer subtypes
por: Iizuka, Misato, et al.
Publicado: (2015)

Expression of CDK7 correlates with molecular subtypes and predicts clinical outcomes in breast cancer
por: Tang, Lin, et al.
Publicado: (2021)

Soluble KIT correlates with clinical outcome in patients with metastatic breast cancer treated with sunitinib
por: Keyvanjah, Kiana, et al.
Publicado: (2012)

Establishing Clinically Significant Outcomes After Meniscal Allograft Transplantation
por: Liu, Joseph N., et al.
Publicado: (2019)

Correlation of TROP-2 expression with clinical–pathological characteristics and outcome in triple-negative breast cancer
por: Izci, Hava, et al.
Publicado: (2022)

Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer
por: Jiang, Wen G, et al.
Publicado: (2006)

Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization
por: Kao, Kuo-Jang, et al.
Publicado: (2011)

Advax Adjuvant: A Potent and Safe Immunopotentiator Composed of Delta Inulin
por: Petroski, N.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g9lnofqf99lclfj3e854ne8vns